Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer

OREM, UT--(Marketwire - Oct 18, 2011) - Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, announced the introduction of the Cryometrix model B-120 blast freezer.

The Cryometrix B-120 builds upon the success of the model T-150 ultra low temperature freezer and utilizes the same patented liquid nitrogen technology. The B-120 is capable of freezing 120 liters of protein material to a -100°C set point in less than 24 hours. This represents a 36 times increase in product throughput as compared to typical standardized processes. Other key features of interest include adaptable payload, low operating costs, no additional HVAC requirements and versatile programming options for step cooling. Dr. Boyd Bowdish, Principal Scientist at Reflect Scientific, commented, "As with the T-150, the B-120 has no compressors, no moving parts involved in the cooling process and with over 1 million T-150 operational hours, the simplified B-120 design is being looked at as a real long term solution to efficient, cost effective freezing protocols for decades to come."

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.